查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1760821

单光子发射电脑断层扫描（SPECT）的全球市场

Single Photon Emission Computed Tomography (SPECT)
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 469 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球单光子发射电脑断层扫描 (SPECT) 市场规模将达到 33 亿美元

全球单光子发射电脑断层扫描 (SPECT) 市场规模预计在 2024 年为 22 亿美元，预计到 2030 年将达到 33 亿美元，2024 年至 2030 年的复合年增长率为 7.1%。心臟科是本报告分析的细分市场之一，预计其复合年增长率为 8.1%，到分析期结束时规模将达到 13 亿美元。肿瘤学细分市场在分析期间内的复合年增长率估计为 7.1%。

美国市场规模估计为 7.9 亿美元，中国市场预计复合年增长率为 9.7%

美国单光子发射电脑断层扫描 (SPECT) 市场规模预计在 2024 年达到 7.9 亿美元。预计到 2030 年，作为世界第二大经济体的中国市场规模将达到 3.986 亿美元，在 2024-2030 年的分析期内，复合年增长率为 9.7%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为 5.8% 和 6.6%。在欧洲，预计德国市场的复合年增长率为 5.7%。

全球单光子发射电脑断层扫描 (SPECT) 市场 - 主要趋势与驱动因素摘要

单光子发射电脑断层扫描 (SPECT) 是一种先进的成像技术，广泛应用于核医领域。此技术透过检测放射性示踪剂发射的伽马射线，可以3D可视化体内的代谢和生理过程。这些示踪剂通常被注入血液并积聚在特定的组织、器官或细胞受体中，具体取决于所用示踪剂的类型。 SPECT 在心臟病学、肿瘤学和神经学方面特别有用，可为冠状动脉疾病、肿瘤以及癫痫和阿兹海默症神经系统疾病提供重要见解。 SPECT 的功能性影像能力使其有别于主要提供解剖资讯的 CT 和 MRI 等其他影像方式。

技术进步显着提高了 SPECT 的功能和应用。 SPECT 与电脑断层扫描 (SPECT/CT) 的结合透过在一次会话中结合功能和解剖影像彻底改变了该领域。这种混合方法提高了诊断准确性并可以更好地定位和表征异常。检测器技术发展的最新趋势，例如使用碲化镉锌 (CZT)检测器，提高了 SPECT 系统的灵敏度和分辨率，从而缩短了采集时间并降低了患者的辐射剂量。此外，影像重建和影像处理软体演算法的进步提高了 SPECT 影像的品质和定量准确性。这些技术创新扩展了 SPECT 在临床和研究环境中的效用，使其成为现代医疗保健的重要工具。

SPECT 市场的成长受多种因素驱动。心血管疾病、癌症和神经系统疾病等慢性疾病的日益普及是主要驱动因素，因为这些疾病通常需要详细的功能性影像来进行诊断和治疗。包括 SPECT/CT 混合系统的开发、检测器材料和影像处理演算法的改进在内的技术进步显着提升了 SPECT 的临床效用和广泛应用。此外，个人化医疗的日益普及以及对精准诊断工具的需求，以及根据患者个别情况制定个人化治疗方案的需求，也推动了 SPECT 等先进影像模式的需求。老年人口的成长，以及他们容易罹患慢性疾病的现状，进一步扩大了 SPECT 的潜在市场。最后，放射性药物的日益普及以及全球核医学设施的扩张也促进了市场的成长。这些因素巩固了 SPECT 市场充满活力和不断发展的特性。

部分

产品类型（独立式、混合式）、应用（心臟科、肿瘤学、神经病学、其他）、最终用途（医院、诊断中心、其他最终用途）

受访公司范例（45家值得关注的公司）

  • GE Healthcare
  • Cardinal Health, Inc.
  • Bruker Corporation
  • Agfa-Gevaert NV
  • Analogic Corporation
  • Biosensors International Group Ltd.
  • Koninklijke Philips NV
  • Bracco SpA
  • Digirad Corporation
  • Bracco Imaging SpA
  • CMR Naviscan Corporation
  • BC Technical, Inc.
  • DDD-Diagnostic A/S
  • Cubresa Inc.
  • Beijing Hamamatsu Photon Techniques, Inc.

人工智慧集成

全球产业分析师正在利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global 特定产业SLM 的典型规范，而是建立了一个从全球专家收集的内容库，其中包括视讯录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • SPECT-CT
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP14973

Global Single Photon Emission Computed Tomography (SPECT) Market to Reach US$3.3 Billion by 2030

The global market for Single Photon Emission Computed Tomography (SPECT) estimated at US$2.2 Billion in the year 2024, is expected to reach US$3.3 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Cardiology, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Oncology segment is estimated at 7.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$790.0 Million While China is Forecast to Grow at 9.7% CAGR

The Single Photon Emission Computed Tomography (SPECT) market in the U.S. is estimated at US$790.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$398.6 Million by the year 2030 trailing a CAGR of 9.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.8% and 6.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.7% CAGR.

Global Single Photon Emission Computed Tomography (SPECT) Market - Key Trends & Drivers Summarized

Single Photon Emission Computed Tomography (SPECT) is a sophisticated imaging technique widely used in the field of nuclear medicine. This modality allows for three-dimensional visualization of metabolic and physiological processes in the body by detecting gamma rays emitted from radioactive tracers. These tracers are typically injected into the bloodstream and accumulate in specific tissues, organs, or cellular receptors, depending on the type of tracer used. SPECT is particularly valuable in cardiology, oncology, and neurology, providing critical insights into conditions such as coronary artery disease, tumors, and neurological disorders like epilepsy and Alzheimer's disease. The ability of SPECT to provide functional imaging distinguishes it from other imaging modalities like CT and MRI, which primarily offer anatomical information.

Technological advancements have significantly enhanced the capabilities and applications of SPECT. The integration of SPECT with computed tomography (SPECT/CT) has revolutionized the field by combining functional and anatomical imaging in a single session. This hybrid approach improves diagnostic accuracy and allows for better localization and characterization of abnormalities. Recent developments in detector technology, such as the use of cadmium zinc telluride (CZT) detectors, have increased the sensitivity and resolution of SPECT systems, enabling faster acquisition times and reduced radiation doses for patients. Furthermore, advancements in software algorithms for image reconstruction and processing have improved the quality and quantitative accuracy of SPECT images. These innovations have expanded the utility of SPECT in both clinical practice and research, making it an indispensable tool in modern healthcare.

The growth in the SPECT market is driven by several factors. Increasing prevalence of chronic diseases such as cardiovascular diseases, cancer, and neurological disorders is a major driver, as these conditions often require detailed functional imaging for diagnosis and management. Technological advancements, including the development of hybrid SPECT/CT systems and improvements in detector materials and image processing algorithms, have significantly enhanced the clinical utility and adoption of SPECT. Additionally, the growing emphasis on personalized medicine and the need for precise diagnostic tools to tailor treatments to individual patients are fueling demand for advanced imaging modalities like SPECT. The rising geriatric population, which is more susceptible to chronic diseases, further expands the potential market for SPECT. Lastly, the increasing availability of radiopharmaceuticals and the expansion of nuclear medicine facilities worldwide are also contributing to market growth. These factors collectively underscore the dynamic and evolving nature of the SPECT market.

SCOPE OF STUDY:

The report analyzes the Single Photon Emission Computed Tomography (SPECT) market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Standalone, Hybrid); Application (Cardiology, Oncology, Neurology, Other Applications); End-Use (Hospitals, Diagnostic Centers, Other End-Uses)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 45 Featured) -

  • GE Healthcare
  • Cardinal Health, Inc.
  • Bruker Corporation
  • Agfa-Gevaert NV
  • Analogic Corporation
  • Biosensors International Group Ltd.
  • Koninklijke Philips N.V.
  • Bracco SpA
  • Digirad Corporation
  • Bracco Imaging SpA
  • CMR Naviscan Corporation
  • BC Technical, Inc.
  • DDD-Diagnostic A/S
  • Cubresa Inc.
  • Beijing Hamamatsu Photon Techniques, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Single Photon Emission Computed Tomography (SPECT) - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • A Prelude to Single-Photon Emission Computed Tomography (SPECT)
    • Prominent Indications for SPECT Scanning
    • Global SPECT Market to Witness Steady Growth over the Coming Years
    • Hybrid SPECT Systems Witness Increased Demand.
    • Cardiology Dominates the Application for SPECT
    • Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
    • United States Dominates the Global SPECT Market, Asia-Pacific to Register Faster Growth
    • Competition
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • SPECT Dominates the Nuclear Medicine Market
    • Global Radiopharmaceuticals Market Revenues in U$ Million for Years 2019, 2021, 2023 & 2025
    • SPECT Systems with Anger Camera Remain the Dominant Type
    • Rapidly Growing Geriatric Population and the Rise in Associated Diseases Catalyze Growth
    • Global Population of 65+ Individuals (In 000s) by Region for the Years 2015, 2020, 2025, 2030 & 2050
    • Rising Incidence of Chronic Diseases Propels the Demand for Medical Imaging
    • Global Cost of Chronic Diseases (In US$ Billion) for the Years 2018 and 2030
    • Oncology Diagnostic Imaging to Witness Rapid Growth
    • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • Growing Emphasis on Early Diagnosis is a Driving Factor for Diagnostic Imaging
    • Rise in Healthcare Expenditure to Drive Growth
    • Elderly Healthcare Expenditure as a % of GDP
    • SPECT Systems with Anger Camera Remain the Dominant Type
    • Growing Demand for Dual-Modality and Organ-Specific Systems Augurs Well
    • Growing Adoption of Hybrid Diagnostic Imaging Modalities
  • SPECT-CT
    • Commercialization of SPECT/CT Systems with Enhanced Features Surges
    • SPECT Combined with CT and PET, the new Rage
    • Integration of X-ray CT Enhances SPECT Capabilities
    • Proper Selection of Isotopes Highly Important for SPECT
    • Sustained Opportunities for Ga-67 SPECT Systems
    • PET Eclipses SPECT in Cardiovascular Imaging
    • Personalized Medicine Drives SPECT Market
    • Drug Ineffectiveness for Select Therapeutic Categories as a Percentage of Patient Population
    • Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019 and 2024
    • Rise in Incidence of Neurological Disorders to Drive Growth
    • Technological Advancements in the Recent Past
    • Yale University Research Team Attempts to use Deep Learning for Estimating Attenuation Maps using SPECT Emission Data
    • Siemens Healthineers Debuts New Version of c.cam Cardiac SPECT System
    • NorthStar Medical Radioisotopes Advances Focus on Therapeutic and Specialized SPECT Radiopharmaceuticals
    • Technological Advancements in Cardiac SPECT
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Standalone by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Standalone by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Standalone by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Hybrid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Hybrid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Hybrid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 28: World Single Photon Emission Computed Tomography (SPECT) Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Single Photon Emission Computed Tomography (SPECT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Single Photon Emission Computed Tomography (SPECT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Single Photon Emission Computed Tomography (SPECT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Single Photon Emission Computed Tomography (SPECT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Single Photon Emission Computed Tomography (SPECT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Single Photon Emission Computed Tomography (SPECT) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • Single Photon Emission Computed Tomography (SPECT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Single Photon Emission Computed Tomography (SPECT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Single Photon Emission Computed Tomography (SPECT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 107: UK Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Spain 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Russia 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Single Photon Emission Computed Tomography (SPECT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Single Photon Emission Computed Tomography (SPECT) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • AUSTRALIA
    • Single Photon Emission Computed Tomography (SPECT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Australia 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Single Photon Emission Computed Tomography (SPECT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 164: India Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: India 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: South Korea 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Single Photon Emission Computed Tomography (SPECT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Single Photon Emission Computed Tomography (SPECT) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Argentina 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Brazil 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Mexico 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Single Photon Emission Computed Tomography (SPECT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Middle East 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Single Photon Emission Computed Tomography (SPECT) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • IRAN
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Iran 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Israel 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: UAE 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Single Photon Emission Computed Tomography (SPECT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Single Photon Emission Computed Tomography (SPECT) by Product Type - Standalone and Hybrid Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Africa 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Product Type - Percentage Breakdown of Value Sales for Standalone and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Single Photon Emission Computed Tomography (SPECT) by Application - Cardiology, Oncology, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Single Photon Emission Computed Tomography (SPECT) by End-Use - Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION